Hypoxia rewires glucose and glutamine metabolism in different sources of skeletal stem and progenitor cells similarly, except for pyruvate.

cell metabolism chondrocyte hypoxia proliferation skeletal progenitor

Journal

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
ISSN: 1523-4681
Titre abrégé: J Bone Miner Res
Pays: England
ID NLM: 8610640

Informations de publication

Date de publication:
11 Jan 2024
Historique:
received: 26 05 2023
revised: 23 11 2023
accepted: 07 12 2023
medline: 13 3 2024
pubmed: 13 3 2024
entrez: 13 3 2024
Statut: aheadofprint

Résumé

Skeletal stem and progenitor cells (SSPCs) are crucial for bone development, homeostasis, and repair. SSPCs are considered to reside in a rather hypoxic niche in the bone, but distinct SSPC niches have been described in different skeletal regions, and they likely differ in oxygen and nutrient availability. Currently it remains unknown whether the different SSPC sources have a comparable metabolic profile and respond in a similar manner to hypoxia. In this study, we show that cell proliferation of all SSPCs was increased in hypoxia, suggesting that SSPCs can indeed function in a hypoxic niche in vivo. In addition, low oxygen tension increased glucose consumption and lactate production, but affected pyruvate metabolism cell-specifically. Hypoxia decreased tricarboxylic acid (TCA) cycle anaplerosis and altered glucose entry into the TCA cycle from pyruvate dehydrogenase to pyruvate carboxylase and/or malic enzyme. Finally, a switch from glutamine oxidation to reductive carboxylation was observed in hypoxia, as well as cell-specific adaptations in the metabolism of other amino acids. Collectively, our findings show that SSPCs from different skeletal locations proliferate adequately in hypoxia by rewiring glucose and amino acid metabolism in a cell-specific manner. Skeletal stem and progenitor cells provide a lifelong cell source for bone-forming osteoblasts and these cells reside in unique microenvironments in different regions of the bone, often characterized by low oxygen levels. It was still unknown whether these regional differences resulted in diverse metabolic profiles. In this study, we show that all types of skeletal stem and progenitor cells can proliferate in low oxygen levels by adapting their metabolism of glucose and amino acids, but they differ in how they modify pyruvate metabolism.

Autres résumés

Type: plain-language-summary (eng)
Skeletal stem and progenitor cells provide a lifelong cell source for bone-forming osteoblasts and these cells reside in unique microenvironments in different regions of the bone, often characterized by low oxygen levels. It was still unknown whether these regional differences resulted in diverse metabolic profiles. In this study, we show that all types of skeletal stem and progenitor cells can proliferate in low oxygen levels by adapting their metabolism of glucose and amino acids, but they differ in how they modify pyruvate metabolism.

Identifiants

pubmed: 38477776
pii: 7516972
doi: 10.1093/jbmr/zjad016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fonds Wetenschappelijk Onderzoek
ID : 1S46318N
Organisme : Research Foundation-Flanders
ID : G.0B3418
Organisme : Juntendo Institute of Mental Health
ID : C24/17/077

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the American Society for Bone and Mineral Research. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Shauni Loopmans (S)

Laboratory of Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven 3000, Belgium.

Guillaume Tournaire (G)

Laboratory of Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven 3000, Belgium.

Ingrid Stockmans (I)

Laboratory of Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven 3000, Belgium.

Steve Stegen (S)

Laboratory of Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven 3000, Belgium.

Geert Carmeliet (G)

Laboratory of Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven 3000, Belgium.

Classifications MeSH